Package 51662-1487-1

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 51662-1487-1
Digits Only 5166214871
Product NDC 51662-1487
Product ID 51662-1487_1200a572-e002-a795-e063-6294a90a59a0
Description

1 mL in 1 VIAL (51662-1487-1)

Marketing

Marketing Status
Marketed Since 2020-01-11
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

GLYCOPYRROLATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "1200a572-e002-a795-e063-6294a90a59a0", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["1731582"], "spl_set_id": ["9be0ad4e-3efa-1a24-e053-2995a90a60d5"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1487-1)", "package_ndc": "51662-1487-1", "marketing_start_date": "20200111"}, {"sample": false, "description": "25 POUCH in 1 BOX (51662-1487-3)  / 1 VIAL in 1 POUCH (51662-1487-2)  / 1 mL in 1 VIAL", "package_ndc": "51662-1487-3", "marketing_start_date": "20210511"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1487_1200a572-e002-a795-e063-6294a90a59a0", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1487", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA090963", "marketing_category": "ANDA", "marketing_start_date": "20200111", "listing_expiration_date": "20261231"}